Kewaunee Scientific Corp
NASDAQ:KEQU
Kewaunee Scientific Corp
NASDAQ:KEQU
Price:
42 USD
10.82%
Updated:
May 15, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
1.5
Current
0.8
Median
2
Industry
Higher
than median
Lower
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=1.5
Enterprise Value
/
130.5m
Invested Capital
85.9m
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| US |
|
Kewaunee Scientific Corp
NASDAQ:KEQU
|
120.8m USD | 1.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.5B USD | 3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
139.8B USD | 12.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 3.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 1.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.5B USD | 3.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 1.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.4B EUR | 1.7 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.2B CNY | 13.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.7B USD | 7.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.3B USD | 15.3 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
